Oral antidiabetic drugs (for primary care physician)

Slides:



Advertisements
Similar presentations
Insulin Therapy in Type 2 Diabetes: Current and Future Directions
Advertisements

NEW ORAL AGENTS IN DIABETES MANAGEMENT
Oral Hypoglycemic Drugs And Classifications
Managing T2DM during Ramadan Dr. Asrar Said Hashem Specialist in Internal Medicine (Al-Amiri Hospital) Fellow of KIMS Endocrine, Diabetes and Metabolism.
Farxiga™ - Dapagliflozin
Oral Medications to Treat Type 2 Diabetes
P H Y S I C I A N S ’ A C A D E M Y F O R C A R D I O V A S C U L A R E D U C A T I O N Oral drugs for type 2 diabetes and all cause mortality in General.
LONG TERM BENEFITS OF ORAL AGENTS
DIABETES Power over Diabetes Presented by: Regina Weitzman, MD.
DIABETES MELLITUS THERAPY. Nutrition Therapy  Weight loss frequently is a primary goal of nutrition therapy because 80% to 90% of people with type II.
Treatment of diabetes:  Life style modification  Insulin  Oral hypoglycemic agents.
Criteria for the diagnosis of DM Symptoms of diabetes plus random blood glucose concentration ≥ 200 mg/dl OR FPG ≥ 126 mg/dl OR Two –hour plasma glucose.
oral hypoglycemic agents
Oral Hypoglycemic Drugs
Clinical Update in Type 2 Diabetes A Case Discussion Dr. Yancey R. Holmes, MD, FACE Ohio Valley Endocrinology.
Oral hypoglycemic drugs Prof. Mohammad Alhumayyd.
Oral hypoglycemic drugs Prof. Mohammad Alhumayyd.
HYPOGLYCEMIC AGENTS Rama B. Rao, M.D. Bellevue Hospital Center/NYUMC New York, N.Y.
Pharmacology of Diabetes Mellitus 2 Dr Emma Baker Consultant Physician/Senior Lecturer in Clinical Pharmacology.
1 Core Defects of Type 2 Diabetes Targeting Mechanisms for a Comprehensive Approach 1 Part 3 of 4.
Oral Hypoglycaemic Agents. Outline 1.What are the available OHG agents and how do they work? 2.Metformin – how much, and how safe? 3.Can I still use TZDS.
Treatment of Diabetes Mellitus Dr. Vereshchahina Natalija.
Practice Points for optimal use of this essential class of drugs in T2DM – Place of SU in current diabetes management – Addressing concerns with SU treatment.
1 Drugs used for Diabetes Mellitus. 2 Introduction There are 2 types of diabetes mellitus: There are 2 types of diabetes mellitus: Type 1: Insulin-dependent.
Type 2 diabetes mellitus in the older patient Shokoufeh Bonakdaran Associate Professor of Endocrinology Mashhad university of medical sciences.
Who is considered elderly? “Young old” years “Old, old” >75 years.
Focus on Diabetes Mellitus NUR 171. How insulin works dia2.us.elsevierhealth.com/ondemand/archieAnimations/423.flv.
Dr. Mansour Alzahrani. متى اكتشف داء السكري؟ داء السكري في الحضارة الهندية والصينية القديمة اسهامات علماء المسلمين في داء السكري.
Dr. Sasan Zaeri (PharmD, PhD) Department of Pharmacology, BPUMS.
Guidelines.diabetes.ca | BANTING ( ) | diabetes.ca Copyright © 2013 Canadian Diabetes Association CHOICE OF AGENT AFTER INITIAL METFORMIN.
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University.
Focus on Diabetes Mellitus NUR 171. How insulin works.
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes William B. White, M.D., Christopher P. Cannon, M.D., Simon R. Heller, M.D., Steven.
1 Core Defects of Type 2 Diabetes Targeting Mechanisms for a Comprehensive Approach 1 Part 4 of 4.
Diabetes in the Pediatric Population
Control of Blood Sugar Diabetes Mellitus.
Diabetes Learning Event 7th October 2016
اصول تجویزومصرف منطقی داروها: مهارکننده الفاگلوکوزیداز
Warfarin in primary care
Objective 2 Discuss recent data, guidelines, and counseling points pertaining to the older adults with diabetes.
Antihyperglycemic Agents and Renal Function
Dr. Sasan Zaeri (PharmD, PhD) Department of Pharmacology, BPUMS
Lecture on Anti Diabetic Drugs
Antihypertensive drugs for primary care physician
Non-Communicable Diseases Unit Lesson 3
Diabetes Mellitus Nursing Management.
Care of Patients with Diabetes Mellitus
Associate Professor Medha Munshi
Cariovascular pharmacology for primary care physician: cardiotonics, antiarrhytmics, vasodilatators Domina Petric, MD.
Oral hypoglycemic drugs
Medications for the respiratory system
Domina Petric, MD Hypolipidemic drugs.
Insulins in primary care setting
Diabetes Health Status Report
Diabetic Disorders 4th Leading cause of deaths in the US
Drugs for Diabetes Mellitus
Use of NOACs is contraindicated for AF patients with mechanical prosthetic valves or moderate- severe mitral stenosis (usually of rheumatic origin). Although.
Empagliflozin (Jardiance®)
Diabetes Jessica Tagerman PharmD
Presented By: Sumia Khan
המשותף לכל סוגי הסוכרת היפרגליקמיה כרונית.
Diabetic Disorders 4th Leading cause of deaths in the US
oral hypoglycemic agents
Introduction to Clinical Pharmacology Chapter 42- Antidiabetic Drugs
Chapter 32 Antidiabetic drugs
Introduction to Clinical Pharmacology Chapter 42 Antidiabetic Drugs
Cholinesterase Inhibitors: Actions and Uses
IRIS Trial Insulin Resistance Intervention after Stroke.
Šafárik University, Košice, Slovakia
Presentation transcript:

Oral antidiabetic drugs (for primary care physician) Domina Petric, MD

I. BIGUANIDES

Metformin It is indicated for adults, adolescents and children more than 10 years old. It is indicated for treatment of diabetes mellitus type 2 (DMT2) when exercise and diet are not sufficient. It is especially indicated for the patients with excessive body weigh.

Metformin Start dose is 500 mg to 850 mg two or three times a day, during the meal or after the meal. Dose can be increased up to maximum dose of 3 g a day divided in two or three doses, if necessary. Metformin can be used in combination with insulin (children, adults) or with other antidiabetic drugs and/or insulin (adults).

Contraindications hypersensitivity diabetic ketoacidosis kidney failure (ClCr<60 mL/min) dehidration severe infections shock heart or respiratory insufficiency recent myocardial infarction liver insufficiency acute alchohol intoxication alchoholism

Rare, but severe complication of metformin accumulation. Lactacidosis Rare, but severe complication of metformin accumulation. Caution is necessary: kidney or liver failure, alchoholics, hypoxia, starving, poorly controled diabetes.

iodine contrast agents Interactions alchohol iodine contrast agents

Pregnancy and lactation Not recommended in pregnancy and lactation!

SULPHONAMIDES, UREA DERIVATES II. SULPHONAMIDES, UREA DERIVATES

Glibenclamide Indicated for DMT2 (insulin independent type of diabetes) patients in monotherapy or in combination with metformin. Start dose is 1,75 mg up to 3,5 mg per os a day. Maximum dose is 10,5 mg per os a day. Drug is taken with full glass of water before meal. In case of higher doses, the total dose is divided in ratio 2:1 = in the morning : in the evening.

Contraindications hypersensitivity insulin dependent diabetes diabetic ketoacidosis diabetic coma severe kidney or liver damage treatment with bosentan pregnancy lactation

Not recommended during pregnancy and lactation. Gliquidone Very good for middle aged or older patients. Start dose is 15 mg per os a day during lunch. Maximum dose is 120 mg per os a day divided in two or three doses. It is not recommended for children and adolescents. Contraindications are: hypersensitivity insulin dependent diabetes diabetic coma severe liver damage infections before surgical procedures Not recommended during pregnancy and lactation.

GLICLAZIDE GLIMEPIRID .... Other sulphonamides GLICLAZIDE GLIMEPIRID ....

ALPHA GLUCOSIDASE INHIBITORS III. ALPHA GLUCOSIDASE INHIBITORS

Acarbose Indicated for DMT2 patients that are not well regulated with metformin or can not take it (or other drugs). Start dose is 50 mg per os three times a day. Maintenance dose is 100 mg per os three times a day. Maximum dose is 200 mg per os three times a day. The drug is taken with the glass of water before meal or during the meal, chewed. Not recommended for children under the age of 18. Contraindications are hypersensitivity, inflammatory bowel disease, bowel obstruction, severe liver or kidney damage (ClCr<25 mL/min).

IV. THIAZOLIDINEDIONES

Pioglitazone It is indicated for DMT2 patients as second or third line therapy: Monotherapy: adults that can not take metformin. Double peroral therapy: with metformin (in adults when metformin as monotherapy is not sufficient) OR with sulphonylureas (when metformin is contraindicated). Triple peroral therapy: with metformin and sulphonylureas OR with insulin therapy. Start dose is 15 mg or 30 mg per os once a day. Maximum dose is 45 mg. Contraindications are hypersensitivity, heart failure (NYHA I to IV), liver damage, diabetic ketoacidosis, macroscopic haematuria, actual or history of urinary bladder carcinoma.

New antidiabetic drugs https://www.slideshare.net/mushtaqhakim/oral-antidiabetics-by-dr-mushtaq-ahmed-associate-professor-pharmacology-pims-punjab

HALMED MEDIATELY www.slideshare.net Literature HALMED MEDIATELY www.slideshare.net